All extends line of laundry pacs
WILTON, Conn. — All laundry detergent, a brand from Sun Products, announced the extension of All mighty pacs with the introduction of All mighty pacs OXI. The pre-measured doses aim to simplify laundry by treating tough dirt stains in a single-dose pac, the company said.
“Launching All mighty pacs OXI is a natural extension for the All business,” said Marissa Mignone, associate brand manager, All Laundry. “With OXI being the fastest-growing variant and single-dose being the fastest growing form, this new product was a must-have introduction to the market, and is delighting consumers.”
All mighty pacs OXI is now available at major retailers. Consumers may also visit All-Laundry.com to find a retailer close to them that carries the product.
Helen of Troy CEO joins board
EL PASO, Texas — Helen of Troy — whose portfolio of personal care products includes Vidal Sassoon, Sure, Pert and Brut — has announced that its board has appointed CEO Julien Mininberg to serve on the board until the next annual meeting of shareholders.
Mininberg’s appointment fills the vacancy created by the departure of Gerald Rubin, the company’s former CEO and a former director of the company. The board intends to nominate Mininberg as a director of the company at the next annual general meeting of shareholders.
“I am pleased to have Julien join our board of directors. Julien is a strong leader who has made significant contributions to Helen of Troy as President and CEO of Kaz and now as CEO for Helen of Troy. It is only fitting that Julien join the Board and benefit more closely from the wisdom of its diverse group of members,” stated Timothy F. Meeker, chairman.
Mininberg has been with Kaz since 2006, becoming president in 2007 and CEO in 2010. Before joining Kaz, Mininberg spent 15 years at Procter & Gamble, where he spent four years in general management and 11 in marketing. His P&G career was split evenly between the United States and Latin America.
FDA approves Topamax for migraine prevention in teenagers
SILVER SPRING, Md. — The Food and Drug Administration on Friday approved Topamax (topiramate) for prevention of migraine headaches in adolescents ages 12 years to 17 years. This is the first FDA approval of a drug for migraine prevention in this age group.
The medication is taken on a daily basis to reduce the frequency of migraine headaches.
Topamax was first approved by the FDA in 1996 to prevent seizures. It was approved for migraine prevention in adults in 2004.
“Migraine headaches can impact school performance, social interactions, and family life,” stated Eric Bastings, deputy director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. “Adding dosing and safety information for the adolescent age group to the drug’s prescribing information will help to inform health care professionals and patients in making treatment choices.”
About 12% of the U.S. population experiences migraine headaches, the FDA noted.
Topamax is manufactured by Janssen Pharmaceuticals of Titusville, N.J.